PM360 PM360 recently spoke to Natalie Cummins, SVP & Chief Commercial Officer at BioReference Laboratories, about a passion for sports and helping to bring them back during the pandemic. PM360: Where did your love of sports originate?Natalie Cummins: I grew up in Syracuse, NY where Syracuse University basketball is the end all be all. My […]
Search Results for: NEW
25
Jan
Jan
Each January brings the opportunity to discuss a topic of great importance in women’s health – cervical cancer. Learning more about cervical cancer and how testing is performed for early detection can help you know your risk. Here, we offer an overview of the disease and the importance of cervical cancer screening. Cervical Cancer Awareness […]
The Spokesman-Review Local health sciences company Gestalt Diagnostics says it has achieved a significant milestone by using artificial intelligence and digital pathology to improve patient care. BioReference Laboratories, an OPKO Health company that serves more than 19 million patients per year, has adopted Gestalt Diagnostics’ digital pathology platform in combination with an algorithm developed by […]
22
Dec
Dec
Each year, the holiday season brings opportunities for festive fun. However, with the emergence of the Omicron variant amid the continuing COVID-19 pandemic, planning for safe holiday activities could still be a challenge. Though reducing your risk of exposure to COVID-19 to zero may be difficult – here, we offer a few creative holiday activities, […]
The Associated Press The NFL is requiring coaches, front-office staff and team personnel to receive a COVID-19 booster by Dec. 27. In a memo sent to teams on Monday and obtained by The Associated Press, the league said: “Given the increased prevalence of the virus in our communities, our experts have recommended that we implement […]
13
Dec
Dec
This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution. BioReference Celebrates 40 […]
08
Dec
Dec
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or […]
02
Dec
Dec
As you may have seen in the news, a new variant of SARS-CoV-2, B.1.1.529, has been classified by the World Health Organization (WHO).1 Named “Omicron,” this variant of concern was first reported in South Africa on November 24, 2021.1 With the first case of this variant in the United States confirmed on December 1, 2021,2 […]
Press Release
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
29
Nov
Nov
According to the Centers for Disease Control and Prevention (CDC), outdoor activities are still safer to take part in than indoor activities due to COVID-19.1 Though, with chilly weather settling in in many regions, this may mean changing some of our go-to adventures. Luckily, fall and winter bring a host of new opportunities to enjoy […]
